Jornada ISCIII-IIS LA Fe. Valencia 2 de julio de 2015

Transcripción

1 The Strategical Conference of EU-Taiwan ICT Technical Cooperation Jornada ISCIII-IIS LA Fe Valencia 2 de julio de 2015 El Reto Social Salud, Cambio Demográfico y Bienestar (SC1) y Salud en otros Retos Salud en otros Pilares de H2020 Juan E. Riese PhD MBA Punto Nacional de Contacto Reto Social 1 H2020 Oficina de Proyectos Europeos Subdirección General de Programas Internacionales de Investigación y Relaciones Institucionales

2 Contenido Hacia la convocatoria WP2016/2017 del SC1 El Instrumento PYME Fast Track to Innovation - FTI Salud en otros pilares 2

3 Hacia la convocatoria del SC1 3

4 El Programa de Trabajo bloques principales: Personalized Medicine (PM): con 22 topics organizados en 6 áreas Co-ordination activities (HCO): con 15 topics Other actions (no sujeto a convocatoria): con 11 topics (topics adicionales en apoyo a la implementación del Reto Social) 4 4

5 El Programa de Trabajo : Áreas Personalised Medicine (PM) 1.1. Understanding health, ageing and disease ( 4 topics) 1.2. Preventing disease ( 3 topics) 1.3. Treating and managing diseases (4 topics) 1.4 Active ageing and self-management of health (4 topics ) 1.5 Methods and data (6 topics) 1.6. Health care provision and integrated care (1 topic) 5 5

6 Posibles Topics SC1 ( ) (3er borrador) 1.1 Understanding health, well-being and disease (4 topics) SC1-PM : Multi omics for personalised therapies SC1-PM : New concepts in patient stratification SC1-PM : Diagnostic characterisation of rare diseases SC1-PM : Networking and optimising the use of population and patient cohorts at EU level 1.2. Preventing disease (3 topics) SC1-PM : The European Human Biomonitoring Initiative SC1-PM : Vaccine development for malaria and/or neglected infectious diseases SC1-PM : Promoting mental well-being in the young 6

7 Posibles topics SC1 ( ) (3 er borrador) 1.3 Treating and managing diseases: (4 topics) SC1-PM : New therapies for rare diseases SC1-PM : New therapies for chronic diseases SC1-PM : Comparing the effectiveness of existing healthcare interventions in the adult population SC1-PM : Clinical research on regenerative medicine 1.4 Active ageing and self-management of health: (4 topics) SC1-PM : PCP - ehealth innovation in empowering the hospitalised patient SC1-PM : PPI for deployment and scaling up of ICT solutions for active and healthy ageing SC1-PM : EU-Japan cooperation on Novel ICT Robotics based solutions for active and healthy ageing at home or in care facilities SC1-PM : Personalised coaching for well-being and care of people as they age 7

8 Posibles topics SC1 ( ) (3er borrador) 1.5 Methods and data: (6 topics -1 is PPI) SC1-PM : In-silico trials for developing and assessing biomedical products SC1-PM : Increasing digital security of health related data on a systemic level SC1-PM : Personalised computer models and in-silico systems for well-being SC1-PM : Big Data supporting Public Health policies SC1-PM : PPI for uptake of standards for the exchange of digitalised healthcare records SC1-PM : Development of new methods and measures for improved economic evaluation and efficiency measures in the health sector 1.6 Health care provision and integrated care: SC1-PM : Implementation research for scaling-up of evidence based innovations and good practice 8

9 Posibles topics SC1 ( ) (3 er borrador) Co-ordination activities: (15 topics, 2 ERA Nets) SC1-HCO : Valorisation of FP7 Health and H2020 SC1 research results SC1-HCO : Standardisation of pre-analytical and analytical procedures for in vitro diagnostics in personalised medicine SC1-HCO : To implement the Strategic Research Agenda on Personalised Medicine SC1-HCO : Towards globalisation of the Joint Programming Initiative on Antimicrobial resistance SC1-HCO : Coordinating personalised medicine research SC1-HCO : Towards an ERA-NET for building sustainable and resilient health care models SC1-HCO : Global Alliance for Chronic Diseases (GACD) SC1-HCO : Actions to bridge the divide in European health research and innovation SC1-HCO : EU m-health hub including evidence for the integration of mhealth in institutional care SC1-HCO : Support for Europe s leading Health ICT SMEs SC1-HCO : Coordinated Action to support the recognition of Silver Economy opportunities arising from demographic change SC1-HCO : Digital health literacy and workforce IT skills SC1-HCO : EU-US interoperability roadmap SC1-HCO : EU ehealth Interoperability conformity assessment SC1-HCO : Standardisation needs in the field of ICT for Active and Healthy Ageing 9

10 Posibles topics SC1 ( ) (3 er borrador) Other Actions: 1. Subscription fee: Human Frontier Science Programme Organisation 2. InnovFin Infectious Diseases (InnovFin ID) Pilot 3. First interim evaluation of the EDCTP2 programme 4. First interim evaluation of the IMI2 programme 5. European registry for human embryonic stem cell lines 6. Tenders studies, activities of the Scientific Panel for Health, and for conferences, events and outreach activities 7. Independent experts assisting in proposal evaluations and assessment, and project reviews 8. Inducement prize on Maternal and Child Health research 9. Grant to the Global Alliance for Chronic Diseases 10. Expert group for alternatives to animal testing 11. Presidency events - ehealth 10

11 2015 Jan mid-may Hacia la convocatoria SC Situación y próximos pasos Preparation of draft WP parts, including: Input on WP content from the Advisory Groups Discussions on WP drafts with the PC configurations Parallel interactions with Policy DGs through the internal Horizon 2020 Groups; and with horizontal directorates on key novelties and features Mid-May Draft WP parts submitted to RTD Units A.3 and R.2 Mid-May to Start- June Start to end-june During July Start-Sept End of September Checking of draft WP parts, interactions with horizontal directorates and preparation of CIS file Inter-service consultation (CIS) Translation and Opinions of PC configurations Preparation of written procedure for the adoption Adoption of the WP for publication of the calls for proposals 11

12 Presupuesto para SC1 conv Approx. 400 M. (2016) y 350 M. (2017) (línea presupuestaria de DG-RTD) Approx. 100 M. (2016) y 87 M. (2017) (línea presupuestaria DG-CNECT) Menor número de acciones con respecto a SC1 WP

13 Calendario de la convocatoria SC El Programa de Trabajo Calendario propuestas: 30 sept 2015 (?): Abre convocatoria enero 2016: 16 febrero 2016: Deadlines abril 2016: 5 meses tras deadline: Resultados evaluación 3 meses tras informar participantes: Firma GA Apertura ? Deadlines 2017: 31 enero 14 marzo 11 abril 13 13

14 A destacar Procedimiento general single-stage (por ahora) PCP y PPI Premio 14

15 El Instrumento PYME - SME instrument 15

16 El Instrumento PYME SME instrument 16

17 El Instrumento PYME SME instrument 17

18 SMEInst en WP SMEInst Supporting innovative SMEs in the healthcare biotechnology sector a) Cell technologies in medical applications (all phase 1 and phase 2 deadlines in 2016 and 2017) b) Clinical research for the validation of biomarkers and/or diagnostic medical devices SMEInst Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Fases 1, 2 y 3 18

19 Diagnostics devices and biomarkers b) Clinical research for the validation of biomarkers and/or diagnostic medical devices (only in 2017 and for phase 2 applications - phasing out of the topic PHC /2015 introduced in the Work Programme ) PHC-12: Clinical research for the validation of biomarkers and/or diagnostic medical devices Prespuesto total para 2014/15: 111 M En 2014: 3 cut-offs en fase 1, 2 en fase 2 En 2015: 4 cut-offs en fases 1 & 2; 2 futuras: 17/09/2015 ; 25/11/2015 Abierto PM-12 fase 2 en 2016 para los que pasaron fase 1 de 2015: 10 M 19

20 Resultados 2014 &

21 Características del SME Instrument Hasta el 100% de financiación en el SC1 vs 70%: hasta 5 M Menos bottom-up en SC1 vs otros retos Template especifico para fases 1 y 2 Convocatoria abierta con fechas de corte: Evaluación: Fase 1: Phase 1 thresholds: Excellence: 4/5 ; Impact: 4/5 ; Implementation: 4/5 Minimum overall threshold: 13/15 Score = Excellence + Impact *1,5 + Implementation Fase 2: Phase 2 thresholds : Excellence: 3/5 ; Impact: 4/5 ; Implementation: 3/5 Minimum overall threshold: 12/15 Score = Excellence + Impact *1,5 + Implementation 21

22 Algunos consejos para el SME Instrument Habla de negocio, no sólo de tecnología Implicación de equipos directivos en fase preparatoria Mapa entidades y proyectos financiados EASME: Video: Novedad: Proyecto MINECO para subvencionar la ejecución de las fases uno mediante financiación nacional 22

23 INSTRUMENTO PYME. Fase 1 FINANCIACIÖN DE LA I+D+i en H2020 Los resultados en Instrumento PYME en ES son exitosos en Fase 2 con 12 de 94 proyectos concedidos Fuente: EASME 23

24 ES en SME Instrument en HEALTH FINANCIACIÖN DE LA I+D+i en H2020 ES coordina 13 proyectos en SME Instrument: 12 Fase 1: - 3 MAD - 2 C.VAL - 2 CyL - 1 AND - 1 ARA - 1 CAT - 1 LR - 1 PV / sme-instrument-phase1-beneficiaries_en.pdf 1 Fase 2: MAD smeinst / sme-instrument-phase2-beneficiaries_en.pdf 24

25 Fast Track to Innovation 25

26 El concepto del FTI Only fully bottom-up measure in Horizon 2020 (within the Societal Challenges and Leadership in Enabling and Industrial Technologies ) Addresses close to the market innovation activities Reduces time from idea to market Increases participation of industry Stimulates private sector investment in research and innovation Time to market: 36 months (from project start) Open to all types of participants Consortium partners with complementary backgrounds, knowledge and skills -> Support of trans-disciplinary and cross sector cooperation Transnational value-chains and EU-wide / global markets are addressed 26

27 Tipos de participante (FTI) Open to all types of participants from EU-member states or associated countries: SMEs Industry First-time industry applicants Universities Research centers Technological organisations Clusters & Associations Incubators End-users Public sector Investors IMPORTANT: Third country partners: only as subcontractors! 27

28 Cómo se participa en FTI? Consortia of min. 3 and max. 5 participants from at least 3 different countries Industry involvement: is mandatory! either at least 60% of overall budget of proposal allocated to industry partners in the consortium or minimum number of industry participants must be 2 in a consortium of 3 or 4 partners and 3 in a consortium of 5 partners Restricted to MS and AC 70% funding rate 28

29 Diferencias instrumentos FTI y SME FTI Fully bottom-up Consortial approach Not SME related Obligatory to be on market after 3 years No coaching support One-stage scheme SME-Instrument Topics 3 phases Single participation possible Restricted to SMEs No obligation to be on market after phase 3 Coaching support 29

30 FTI: fechas de corte y presupuesto

31 Condiciones de la convocatoria For 2015 and 2016: 200 Mio ( ) About actions (projects) will be funded / year Grants for up to 3 Mio possible (maximum!) -> approximately 20 actions per Cut-off to be funded for all themes (bottom-up!) End of July: results of first evaluation Highest competition and very high oversubscription to be expected! 31

32 Actividades a financiar Advanced and specific research and development Advanced performance testing Piloting Demonstration activities Final validation of a system in the operational environment Business model validation Marketing activities (not purely commercial) Activities for strategic commercial and technical relevance Level of development: Technology readiness level (TRL) TRL 6 -> TRL 9 in very short time frame TRL 6 is minimum requirement (demonstration in a relevant environment): 32

33 La evaluación en FTI (I) Each proposal will be evaluated by 4 different experts: ATTENTION: Evaluators are not necessarily from your research area! Thresholds: Overall score of 12 out of 15 Score for Impact at least 4 out of 5 Evaluation occurs fully remote, no consensus meetings Final scores: arithmetic average of individual scores Evaluation summary reports with short feedback sent to you 33

34 El ranking All proposals reaching the thresholds will be ranked Score for impact will be multiplied with 1.5 before the ranking starts! Additional criteria for evaluation: 1. Value of impact criterion 2. Size of budget allocated to SMEs 3. Number of first-time industry applicants 4. Number of industry applicants 5. Gender balance of consortium staff performing the action 34

35 35

36 Pilar 1 ERC-IDEAS: M (presupuesto duplicado frente a PM7) Más enfocado jóvenes investigadores e investigación básica, pero Sin olvidar la visión sobre el impacto de la investigación! FET (Tecnologías Futuras y Emergentes): M - Las TIC como herramientas para alcanzar objetivos Marie Sklodowska Curie (Movilidad): M Infraestructures (ESFRI): M (x2 en comparación con PM7) Instrumento para avanzar en el Espacio Europeo de Investigación (ERA) Promover el acceso a infraestructuras europeas de I+D+i 36

37 Pilar 2 1) Liderazgo en tecnología facilitadoras de aplicación industrial (LEITs) M 1.1 ICT (sin E-Salud) M 1.2, 1.3 y 1.5: Nanotec., materiales y producción M 1.4 Biotecnología 509 M 1.6 Espacio M 2) Acceso a Capital Riesgo M 3) Innovación para PYMEs 619 M 37

38 Posibles topics relacionados con biomedicina en el Pilar 2 (Liderazgo industrial) NMBP Biomaterials for treatment and prevention of multiple sclerosis NMBP Nanoformulation of biologicals NMBP (2016?) Nanotechnologies for imaging cellular trasplants and regenerative processes in vivo 38

39 La Oficina de Proyectos Europeos (OPE-ISCIII) Personal Asesores científicos Teresa Corral Tel.: ; Gloria Villar Tel.: ; gvillar@eu-isciii.es NCP Infraestructuras de Investigación Juan E. Riese (NCP - Salud) Tel.: ; jriese@eu-isciii.es NCP SC1 y Experto en el CP Especialista en cuestiones financieras Gonzalo Arévalo (NCP legal y financiero) Tel.: ; garevalo@eu-isciii.es NCP Cuestiones Legales y Financieras Especialista en cuestiones legales Lucía del Río (NCP - IDEAS) Tel.: ; ldrio@eu-isciii.es NCP ERC Especialista en relaciones con la CE Marta Barrionuevo Tel.: ; mbarrionuevo@eu-isciii.es Especialista en convocatorias, documentación y boletín Laura Mohedano Tel.: ; lmohedano@isciii.es Personal relacionado con proyectos: Sara García Rodríguez sgrodriguez@eu-isciii.es Mónica de Román mdroman@eu-isciii.es Mercedes García mgarciag@eu-isciii.es 39

40 Juan E. Riese 40